To determine whether human AML-derived eosinophil-like cells could revert to an immature proliferative state we sorted the SSCHIGHCD11B+CD15– eosinophil population from 6 day ATRA/GM-CSF treated HT93 cultures, then withdrew ATRA/GM-CSF. The gene discussed is FUT4; the disease is acute myeloid leukemia.